← All trials
NCT05009680
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 9, 2021
- Primary completion
- May 18, 2022
- Completion date
- Sep 10, 2022
- First posted
- Aug 17, 2021
- Last posted
- Nov 29, 2021
- Enrollment
- 54
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Galecto BiotechLead sponsor
- Comac MedicalOverall official - principal investigator
- Comac MedicalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.